viewIronRidge Resources Ltd

IronRidge Resources finds highest grade lithium so far at Ghana project

"We are very pleased with the ongoing results received, which have confirmed high grades and mineralisation continuity," said chief executive Vincent Mascolo

IronRidge Resources Ltd -

IronRidge Resources Ltd (LON:IRR) found its highest grade lithium yet from an ongoing drilling programme at new targets adjacent to the Ewoyaa lithium project in Ghana, West Africa.

Multiple high-grade lithium pegmatite intersections were found in initial drilling alongside the highest grade of 4% lithium oxide over 1 metre from a depth of 62 metres, it said.

"We are very pleased with the ongoing results received, which have confirmed high grades and mineralisation continuity over 400m of strike, with true mineralised pegmatite widths up to 25m which remains open at depth and along strike to the east,” said chief executive Vincent Mascolo.

"We are confident the additional targets will increase resource scale and improve project economics, where we have defined Ghana's first lithium JORC compliant resource,” he said.

The Ewoyaa lithium project has a JORC-compliant mineral resource estimate of 14.5 million tonnes at 1.31% lithium oxide in the inferred and indicated category.

Quick facts: IronRidge Resources Ltd


Price: 19.7 GBX

Market Cap: £113.03 m

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events


The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of named herein, including the promotion by the Company of in any Content on the Site, the Company receives from said issuer annual cash...


FTSE 100 starts the shortened trading week flat

FTSE 100 was going nowhere at the start of trading even though US markets hit new record highs overnight. London’s blue-chip index was almost unchanged at 7,148 in early dealings. GlaxoSmithKline has started phase III trials of a Covid-19 vaccine that will test itself against rival...

3 weeks, 2 days ago

2 min read